MedPath

Volunteering as an Intervention to Reduce Depression Among Adolescents

Not Applicable
Completed
Conditions
Depression
Adolescent Behavior
Depressive Symptoms
Interventions
Behavioral: Volunteer experience
Registration Number
NCT03816215
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

The purpose of the present study is to test in a preliminary manner an innovative strategy for treating depression among adolescents (alongside existing therapy) using community volunteerism.

Detailed Description

The purpose of the present study is to test in a preliminary manner an innovative strategy for treating depression among adolescents (alongside existing therapy) using community volunteerism. In addition, this study will test a potential mechanism by which volunteering might decrease depressive symptoms: increasing psychosocial assets, specifically decreasing self-orientation and increasing an orientation toward others. This will be measured through self-report as well as using functional magnetic resonance imaging (fMRI). This study will be the first study to explore how neural response patterns are potentially altered by intense experiences with volunteerism among depressed adolescents.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
9
Inclusion Criteria
  • age 14-20
  • new mild to moderate depression diagnosis (single episode)
  • new mild to moderate anxiety diagnosis
  • new adjustment disorder diagnosis
  • have been in treatment for < 8 months
  • right-handed
Read More
Exclusion Criteria
  • history of recurrent depressive, anxiety or adjustment disorder episodes
  • have been in treatment > 8 months
  • left-handed
  • expressing suicidal ideation
  • claustrophobia
  • any contraindications for completing an MRI scan
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Adolescent ParticipantsVolunteer experienceParticipants will be assigned to participate in community service (from a menu of options) for 30 hours.
Primary Outcome Measures
NameTimeMethod
Participant recruitment6 months

Number of participants screened (reported by clinical mental health providers)

Participant retention6 months

Number of participants retained in full study

Depressive symptoms (Beck Depression Inventory)6 months

Beck Depression Inventory to measure depressive symptoms. Each item is rated on a 4-point scale ranging from 0 to 3. The minimum total score is 0 and the maximum total score is 63. Higher scores denote worse outcome

Secondary Outcome Measures
NameTimeMethod
Self-efficacy6 months

NIH toolbox measure from 1 (never) to 5 (very often); scores will be averaged and high score indicates more self-efficacy.

Empathy6 months

IRI (Interpersonal Reactivity Index) subscale to measure empathy on a 5 point scale from 1- strongly disagree to 5 -strongly agree. Scores will be averaged; higher score denotes more empathy.

Strength of Connectivity in DMN (Default Mode Network)6 months

Default Mode Network Connectivity will be measured using fMRI at rest and while processing emotional pictures before and after volunteering intervention. The strength of connectivity within the DMN will be calculated by averaging attributes for each node in the DMN.

Hope scale (Abler et al., 2017)6 months

Hope scale (Abler et al., 2017) will be measured on a scale from 1 (strongly disagree) to 5 (strongly agree). Items will be averaged; higher scores denote better outcome (more hope).

Beck Hopelessness Inventory6 months

Beck Hopelessness Inventory will be used (scored from 1-20; higher score denotes worse outcome).

Orientation Toward Others6 months

5 point scale from 1=strongly disagree to 5=strongly agree. Scores will be averaged; higher score denotes more orientation toward others.

Trial Locations

Locations (3)

Trinity Center, Inc

🇺🇸

Winston-Salem, North Carolina, United States

TriCare, PA

🇺🇸

Winston-Salem, North Carolina, United States

Private practice

🇺🇸

Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath